Merrimack Pharmaceuticals' IPO

Merrimack Pharmaceuticals raised a round of funding on March 29, 2012. Investors include Public.

Merrimack Pharmaceuticals (NASDAQ: MACK) is a biopharmaceutical company discovering, developing, and commercializing medicines paired with companion diagnostics for the treatment of serious diseases, …

Articles about Merrimack Pharmaceuticals' IPO: